Comparison

Vedolizumab European Partner

Item no. HY-P9911-25mg
Manufacturer MedChem Express
CASRN 943609-66-3
Amount 25 mg
Quantity options 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Antibody Monoclonal
Specific against other
Purity 99.90
Dry ice Yes
Citations [1]Soler D, et al. The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrintherapeutic antibody in development for inflammatory bowel diseases. J Pharmacol Exp Ther. 2009 Sep;330(3):864-75.|[2]Singh H, et al. Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease. J Nat Sci Biol Med. 2016 Jan-Jun;7(1):4-9.
Smiles [Vedolizumab]
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Alias Anti-Human lymphocyte α4β7 integrin,Humanized Antibody
Similar products 943609-66-3
Shipping Condition Dry ice
Available
Manufacturer - Type
Inhibitory Antibodies
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Integrin
Shipping Temperature
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Molecular Weight
(146.868 kDa)
Product Description
Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Manufacturer - Research Area
Inflammation/Immunology; Cancer
Solubility
10 mM in H2O
Manufacturer - Pathway
Cytoskeleton
Clinical information
Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close